A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Clinical trial NCT04232553 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04232553
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-22
- Primary completion
- 2024-11-28
- Enrollment
- 996
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.